Axogen (AXGN) EVP Marc Began Exercises Options, Sells 67,500 Shares

What Happened

• Marc A. Began, Executive Vice President & General Counsel of Axogen, exercised 67,500 stock options at a strike price of $8.16 (cost $550,800) on August 10, 2026 and sold those 67,500 shares the same day at a weighted-average price of $47.34 for gross proceeds of about $3,195,788. The filing also reports the related derivative (the option) as disposed at $0, reflecting conversion/exercise.

Key Details

• Transaction date: August 10, 2026 (Form 4 filed Aug 12, 2026 — within the usual 2-business-day filing window).
• Exercise: 67,500 shares acquired @ $8.16; total exercise cost $550,800.
• Sale: 67,500 shares sold @ weighted avg $47.34 (prices ranged $47.16–$47.72) for ~ $3,195,788 in gross proceeds.
• Reporting plan: Sales executed pursuant to a Rule 10b5-1 trading plan adopted March 11, 2026 (footnote F1).
• Vesting note: The filing includes a vesting schedule for the related option grant (fully vested by Mar 1, 2027; 50% vests Mar 1, 2025, then 12.5% every 6 months) (footnote F3).
• Shares owned after the transaction: not specified in the provided Form 4 summary.
• Filing timeliness: Filed Aug 12 for an Aug 10 transaction — appears timely.

Context

• This was an exercise-and-sell (same-day sale) transaction: the options were converted into shares and those shares were immediately sold — a common way to realize value and cover option costs/taxes.
• The sale was run under a pre-established 10b5-1 plan, which typically structures planned insider sales and reduces concerns about trading on recent non-public information.
• The weighted-average sale price and price range are reported; the filer can provide a breakdown of shares sold at each individual price upon request (footnote F2).

Note: This summary is factual and does not infer the insider's motivation.